<DOC>
	<DOCNO>NCT01174095</DOCNO>
	<brief_summary>The primary aim study ass follow-up subject receive AdGVVEGF121cDNA IRB protocol # 0794-894 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease '' IRB protocol # 0297-693 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease Via Minimally Invasive Surgery '' .</brief_summary>
	<brief_title>Post Ten Year Follow Assessment Phase I Trial Angiogenic Gene Therapy</brief_title>
	<detailed_description>A research coordinator Weill Cornell Medical College survey medical record 31 subject , obtain contact information living subject . Living subject call research coordinator Stony Brook University Medical Center invite participate current follow-up study , entail full medical chart review . If potential subject interested , he/she invite Stony Brook University Medical Center Dr. Rosengart designate co-investigator conduct informed consent process . However , subject unable travel Stony Brook University Medical Center mail consent form . Those consent participate compile medical record send Stony Brook University Medical Center . The research coordinator Stony Brook conduct chart review order collect information regard subject 's medication , evaluation surgical history past 10 year . This information include cardiac health evaluation 99mTc-sestamibi SPECT , treadmill exercise tolerance test cardiac specific blood test . These parameter compare evaluation do baseline evaluation do subject 's last visit participant either Institutional Review Board ( IRB ) protocol # 0794-894 # 0297-693 .</detailed_description>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Ischemia</mesh_term>
	<criteria>Subjects study recruit population subject participate 2 previous Weill Cornell Medical College IRB gene transfer study use AdGVVEGF121.10 : 1 . IRB protocol # 0794894 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease '' 2 . IRB protocol # 0297693 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease Via Minimally Invasive Surgery . '' Subjects study recruit population subject participate 2 previous Weill Cornell Medical College IRB gene transfer study use AdGVVEGF121.10 : 1 . IRB protocol # 0794894 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease '' 2 . IRB protocol # 0297693 entitle `` Phase I Study Direct Administration Replication Deficient Adenovirus Vector ( AdGVVEGF121.10 ) Containing VEGF121 cDNA Ischemic Myocardium Individuals Diffuse Coronary Artery Disease Via Minimally Invasive Surgery . ''</criteria>
	<gender>All</gender>
	<minimum_age>60 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>October 2016</verification_date>
	<keyword>Diffuse Coronary Artery Disease</keyword>
	<keyword>Ischemic Myocardium</keyword>
	<keyword>Ischemia</keyword>
</DOC>